Candriam S.C.A. Sells 10,200 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Candriam S.C.A. decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.0% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 246,867 shares of the medical equipment provider’s stock after selling 10,200 shares during the period. Intuitive Surgical makes up about 0.7% of Candriam S.C.A.’s portfolio, making the stock its 29th biggest position. Candriam S.C.A. owned about 0.07% of Intuitive Surgical worth $109,814,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of ISRG. Indiana Trust & Investment Management CO lifted its holdings in shares of Intuitive Surgical by 5.3% in the second quarter. Indiana Trust & Investment Management CO now owns 500 shares of the medical equipment provider’s stock worth $222,000 after acquiring an additional 25 shares during the last quarter. Hoxton Planning & Management LLC lifted its stake in shares of Intuitive Surgical by 4.9% in the 2nd quarter. Hoxton Planning & Management LLC now owns 534 shares of the medical equipment provider’s stock valued at $238,000 after acquiring an additional 25 shares during the last quarter. First Affirmative Financial Network boosted its holdings in shares of Intuitive Surgical by 2.7% during the 2nd quarter. First Affirmative Financial Network now owns 996 shares of the medical equipment provider’s stock valued at $443,000 after acquiring an additional 26 shares in the last quarter. Advance Capital Management Inc. raised its position in Intuitive Surgical by 3.8% in the first quarter. Advance Capital Management Inc. now owns 740 shares of the medical equipment provider’s stock valued at $295,000 after purchasing an additional 27 shares during the last quarter. Finally, Perigon Wealth Management LLC increased its stake in shares of Intuitive Surgical by 0.5% in the first quarter. Perigon Wealth Management LLC now owns 5,363 shares of the medical equipment provider’s stock valued at $2,140,000 after buying an additional 27 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 1.0 %

Intuitive Surgical stock opened at $471.82 on Friday. The firm has a market capitalization of $167.35 billion, a price-to-earnings ratio of 85.17, a P/E/G ratio of 5.43 and a beta of 1.39. The firm has a 50 day simple moving average of $458.74 and a 200 day simple moving average of $417.98. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $493.97.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.24. The company had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The firm’s quarterly revenue was up 14.5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.18 earnings per share. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 396 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $486.88, for a total value of $192,804.48. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,680,761.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, SVP Henry L. Charlton sold 40,243 shares of Intuitive Surgical stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the sale, the senior vice president now owns 3,001 shares in the company, valued at approximately $1,461,006.84. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 396 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $486.88, for a total value of $192,804.48. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,680,761.28. The disclosure for this sale can be found here. Insiders sold 51,656 shares of company stock valued at $24,700,644 in the last quarter. 0.90% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on ISRG. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their price objective for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Evercore ISI decreased their target price on Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating for the company in a research note on Friday, July 19th. Stifel Nicolaus lifted their target price on Intuitive Surgical from $430.00 to $475.00 and gave the stock a “buy” rating in a report on Friday, July 19th. Citigroup increased their price objective on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Finally, Barclays upped their target price on Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research report on Thursday, July 18th. Six equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $446.45.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.